CJC-1295

Detailed Definition

Modified growth hormone releasing hormone (GHRH) analog with extended half-life. This peptide has been the subject of extensive research investigations examining its molecular mechanisms, biological activities, and potential therapeutic applications. Research protocols involving this compound typically emphasize proper handling, storage, and administration procedures to ensure experimental validity. Scientific studies have characterized its pharmacokinetic properties, receptor interactions, and dose-response relationships across various experimental models. All research applications are conducted in licensed laboratory facilities by trained personnel following established safety protocols.